The result of these efforts has been the launch of RRD's Product Development Team (PDT) model, an effective, asset-centric alternative to traditional industry practices. Comprehensive in scope, encompassing all aspects of product development, the PDT model is resource efficient with an intense focus on minimizing cost, time and risk to achieve human proof-of-concept (POC).
"We have evolved and grown by improving how RRD works, the value we provide and the way we deliver it," said Scott Tarrant, President, RRD International. "As President, I will be responsible for leveraging the PDT model to further build the business and distinguish the benefits of our approach among investors, partners and prospective clients."
Prior to joining RRD International, Tarrant served as Executive Vice President of Global Sales and Marketing for UK-based Xceleron Ltd and led the formation of its US subsidiary in Maryland. He currently serves on the Board of Directors for Accium BioSciences, Inc and Carepeutics, Inc and has previously held executive and sales management positions at Gene Logic, TherImmune Research Corporation and Nalco Chemical Company.
Tarrant is a former combat engineer officer in the United States Army. He received his B.S. in Biology from SUNY College of Environmental Science and Syracuse University and is a graduate of the International Executive Program in General Management at INSEAD, Fontainebleau, France and Singapore.
About RRD International:
RRD International is a product development company that provides integrated, expert-level strategic,
|SOURCE RRD International|
Copyright©2012 PR Newswire.
All rights reserved